• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Thyroid Hormone Therapy and Incident Stroke
CONCLUSIONS: Both exogenous hyper- and hypothyroidism were associated with increased risk of stroke, highlighting the importance of patient medication safety.PMID:34137866 | DOI:10.1210/clinem/dgab444
Source: The Journal of Clinical Endocrinology and Metabolism - June 17, 2021 Category: Endocrinology Authors: Maria Papaleontiou Deborah A Levine David Reyes-Gastelum Sarah T Hawley Mousumi Banerjee Megan R Haymart Source Type: research

Menopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery.
CONCLUSIONS: Although HT continues to have an important role in menopause management, it is not recommended for primary or secondary CVD prevention. Different formulations, doses, and routes of delivery of HT have different effects on cardiometabolic markers and risks of clinical CVD events. However, long-term trials evaluating clinical outcomes with transdermal and other alternate HT regimens are limited. PMID: 33506261 [PubMed - as supplied by publisher]
Source: The Journal of Clinical Endocrinology and Metabolism - January 28, 2021 Category: Endocrinology Authors: Shufelt CL, Manson JE Tags: J Clin Endocrinol Metab Source Type: research

Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis.
Conclusions: Low quality evidence suggests that sex steroid therapy may increase LDL-C and TG and decrease HDL-C levels in FTM, while oral estrogens may increase TGs in MTF. Data about patient important outcomes remain sparse. PMID: 28945852 [PubMed - as supplied by publisher]
Source: The Journal of Clinical Endocrinology and Metabolism - September 13, 2017 Category: Endocrinology Authors: Maraka S, Singh Ospina N, Rodriguez-Gutierrez R, Davidge-Pitts CJ, Nippoldt TB, Prokop LJ, Murad MH Tags: J Clin Endocrinol Metab Source Type: research

Increased cardiovascular mortality risk in women discontinuing postmenopausal hormone therapy.
CONCLUSIONS: Increased cardiovascular death risks question the safety of annual HT discontinuation practice to evaluate whether a woman could manage without HT. PMID: 26414962 [PubMed - as supplied by publisher]
Source: The Journal of Clinical Endocrinology and Metabolism - September 28, 2015 Category: Endocrinology Authors: Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O Tags: J Clin Endocrinol Metab Source Type: research